STOCK TITAN
  1. Home
  2. EQRX

Eqrx (EQRX) Stock Price, News & Analysis

EQRX NASDAQ

Company Description

Eqrx (NASDAQ: EQRX) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for EQRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
-8.70%

EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results

earnings
-3.57%

EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023

conferences earnings date
+1.38%

EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress

earnings
+1.22%

EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference

conferences
-2.29%

EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer

+7.69%

EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer

Eqrx has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences, earnings date. View all EQRX news →

SEC Filings

View All

No SEC filings available for EQRX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

EQRX Company Profile & Sector Positioning

Eqrx (EQRX) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.